Literature DB >> 6600600

Hyperparathyroidism in the elderly.

S Tibblin, N Pålsson, J Rydberg.   

Abstract

Primary hyperparathyroidism was studied in a well-defined geriatric population of 1129 individuals during a three-month interval. Primary hyperparathyroidism was diagnosed in 1.5%. The diagnosis was based on a morphologic and biochemic basis. From clinical material consisting of 400 patients treated surgically for primary hyperparathyroidism during a ten-year period, 158 patients (38%) above the age of 64 were studied. At the preoperative evaluation, neuromuscular symptoms were present in 80%, renal insufficiency and kidney stones in each 16%, constipation and/or anorexia in 38%. Ten per cent were considered asymptomatic. In 80% the primary hyperparathyroidism was caused by a solitary adenoma. Ninety-four per cent became normocalcemic following the operation. Consistent hypocalcemia requiring vitamin-D treatment occurred in 3%, and 2% had a persisting hypercalcemia or later recurrence. The therapeutic effect on the neuromuscular symptoms, constipation, anorexia, and renal stone formation was considered good or fair in most of the cases. Primary hyperparathyroidism in the elderly occurs with a high prevalence. It can be treated successfully by surgical therapy with a low cost of morbidity, mortality, and medical care.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6600600      PMCID: PMC1353100          DOI: 10.1097/00000658-198302000-00003

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  4 in total

1.  Psychiatric disorders in primary hyperparathyroidism.

Authors:  P Petersen
Journal:  J Clin Endocrinol Metab       Date:  1968-10       Impact factor: 5.958

2.  Prevalence of hypercalcaemia in a health screening in Stockholm.

Authors:  T Christensson; K Hellström; B Wengle; A Alveryd; B Wikland
Journal:  Acta Med Scand       Date:  1976

3.  Primary hyperparathyroidism. Incidence, morbidity, and potential economic impact in a community.

Authors:  H Heath; S F Hodgson; M A Kennedy
Journal:  N Engl J Med       Date:  1980-01-24       Impact factor: 91.245

4.  Primary hyperparathyroidism: changes in the pattern of clinical presentation.

Authors:  G R Mundy; D H Cove; R Fisken
Journal:  Lancet       Date:  1980-06-21       Impact factor: 79.321

  4 in total
  4 in total

1.  In a population study, can parathyroid hormone aid the definition of adequate vitamin D status? A study of people aged 65 years and over from the British National Diet and Nutrition Survey.

Authors:  C J Bates; G D Carter; G D Mishra; D O'Shea; J Jones; A Prentice
Journal:  Osteoporos Int       Date:  2003-02-26       Impact factor: 4.507

2.  "Limited" parathyroidectomy in geriatric patients.

Authors:  G L Irvin; D M Carneiro
Journal:  Ann Surg       Date:  2001-05       Impact factor: 12.969

Review 3.  Hyperparathyroidism in the elderly patient.

Authors:  Rebecca Sims; Charanjeit Ubhi; David Hosking
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

4.  The influence of surgery on the risk of death in patients with primary hyperparathyroidism.

Authors:  G Hedbäck; A Odén; L E Tisell
Journal:  World J Surg       Date:  1991 May-Jun       Impact factor: 3.352

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.